OliveX : Exercise of options

WWW.NSXA.COM.AU

ABN: 11 000 902 063

Application for Quotation of Additional Securities

File Reference:

I:IssuersFormswebsite formsdocuments 2016issuersNSX Quotation of Additional Securities.doc

	Application for quotation of additional securities
Table of Contents
INTRODUCTION.....................................................................................................................	2
NEW ISSUE ANNOUNCEMENT, APPLICATION FOR QUOTATION OF ADDITIONAL
SECURITIES AND AGREEMENT ..........................................................................................	3
PART 1	- ALL ISSUES ...........................................................................................................	3
PART 2	- BONUS ISSUE OR PRO RATA ISSUE ................................................................	5
PART 3	- QUOTATION OF SECURITIES ..............................................................................	7
ADDITIONAL SECURITIES FORMING A NEW CLASS OF SECURITIES ..............................................	7
QUOTATION AGREEMENT...................................................................................................	9

Introduction

To ensure the efficient processing of this form by NSX, please:

1. Adhere to the suggested number of the annexures required by this form.
2. Complete all statements and questions in this form. (NSX can provide an electronic version of this form on request).

Page 2 of 9

Application for quotation of additional securities

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to NSX as soon as available. Information

and documents given to NSX become NSX's property and may be made public.

Introduced 11 March 2004. Revised 7 March 2016.

Name of entity

OLIVEX HOLDINGS LIMITED

ABN/ACN

12 631 675 986

We (the entity) give NSX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1. Class of securities issued or to be issued
2. Number of securities issued or to be issued (if known) or maximum number which may be issued
3. Principal terms of the securities (eg, if options, exercise price and
   expiry date; if partly paid securities, the amount outstanding and due dates for payment; if
   convertible securities, the conversion price and dates for conversion)

Ordinary Shares

100,000

Options - Lead Manager, exercise price $0.20, expiry 24/08/2023

4 Do the securities rank equally in Yes all respects from the date of allotment with an existing class of quoted securities?

If the additional securities do not rank equally, please state:

• the date from which they do
• the extent to which they
  participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Page 3 of 9

Application for quotation of additional securities

1. Issue price or consideration
2. Purpose of the issue
   (If issued as consideration for the acquisition of assets, clearly identify those assets)

1. Dates of entering securities into
   uncertificated holdings or despatch of certificates
2. Number and class of all
   securities quoted on NSX (including the securities in clause 2 if applicable)

$0.20 per share

Exercise of options

11/08/2022

Number	Class
86,783,301	Ordinary Shares

9 Number and class of all securities not quoted on NSX (including the securities in clause 2 if applicable)

10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Number	Class
8,629,878	Ordinary Shares
3,700,000	Options - Lead Manager
50,200	Options - MITP Agency
50,000	Options - Service Provider
1,060,000	Class A Director Options
1,060,000	Class B Director Options
750,000	Class C Director Options
210,779	Trance A Performance Rights
316,168	Trance B Performance Rights
237,126	Trance C Performance Rights
355,688	Trance D Performance Rights
302,993	Trance E Performance Rights
454,488	Trance F Performance Rights
16,250	Class C Performance Rights
472,976	MD Performance Rights

N/A

Page 4 of 9

Application for quotation of additional securities

Part 2 - Bonus issue or pro rata issue

1. Is security holder approval required?
2. Is the issue renounceable or non- renounceable?
3. Ratio in which the securities will be offered
4. Class of securities to which the offer relates
5. Record date to determine entitlements
6. Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

N/A

N/A

N/A

N/A

N/A

1. Policy for deciding entitlements in relation to fractions
2. Names of countries in which the entity has security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

N/A

N/A

1. Closing date for receipt of acceptances or renunciations
2. Names of any underwriters
3. Amount of any underwriting fee or commission
4. Names of any brokers to the issue
5. Fee or commission payable to the broker to the issue
6. Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

N/A

N/A

N/A

N/A

N/A

N/A

Page 5 of 9